Workflow
GE HealthCare Technologies (NasdaqGS:GEHC) 2026 Conference Transcript
2026-02-26 15:32
GE HealthCare Technologies (NasdaqGS:GEHC) 2026 Conference February 26, 2026 09:30 AM ET Company ParticipantsJay Saccaro - CFOJoanne Wuensch - Managing Director and Head of U.S. Healthcare ResearchPhil Rackliffe - President and CEO of Advanced Visualization SolutionsJoanne WuenschI don't even know where to start. I'm gonna start off big picture, which is always the best place to think about this. Tell me what you're seeing in the market.Jay SaccaroYeah, great.Joanne WuenschI mean, this year we entered the m ...
Pharvaris (NasdaqGS:PHVS) FY Conference Transcript
2026-02-26 15:22
Pharvaris (NasdaqGS:PHVS) FY Conference February 26, 2026 09:20 AM ET Company ParticipantsBerndt Modig - CEOMaggie Beller - Executive Director and Head of Corporate and Investor CommunicationsConference Call ParticipantsJeff Jones - Managing Director and Senior Analyst of BiotechnologyJeff JonesMorning, everyone, and welcome back to Oppenheimer's Healthcare Conference. I'm Jeff Jones, one of the analysts on the biotech team, and I'm delighted to welcome this morning, Berndt Modig, CEO of Pharvaris, as well ...
CEMEX (NYSE:CX) 2026 Investor Day Transcript
2026-02-26 15:02
CEMEX (NYSE:CX) 2026 Investor Day February 26, 2026 09:00 AM ET Company ParticipantsAlejandra Obregon - Executive DirectorAnne Milne - Managing Director of Emerging Markets Corporate ResearchBen Theurer - Managing Director and Head of Equity Research for LatAmCarlos Peyrelongue - Head of Mexico Equity ResearchFrancisco Suarez - Global Director of Research for LatAm EquitiesGarrett Greenblatt - Equity Research Associate for US Construction MaterialsJaime Muguiro - CEOJeff Bobolts - SVP of US AggregatesJesús ...
Aprea Therapeutics (NasdaqCM:APRE) FY Conference Transcript
2026-02-26 14:42
Aprea Therapeutics (NasdaqCM:APRE) FY Conference February 26, 2026 08:40 AM ET Company ParticipantsOren Gilad - President and CEONone - AssociateNoneMorning, everyone, thanks for joining us. My name is Anthony, and I'm an associate here at Oppenheimer. It's my pleasure to introduce Aprea Therapeutics, a precision oncology company focused on targeting the DNA damage response pathway. Their lead program is APRN-1051, a next-gen WEE1 inhibitor. The company is also advancing ATRN-119, a macrocyclic ATR inhibito ...
Aclaris Therapeutics (NasdaqGS:ACRS) FY Conference Transcript
2026-02-26 14:42
Aclaris Therapeutics (NasdaqGS:ACRS) FY Conference February 26, 2026 08:40 AM ET Company ParticipantsHugh Davis - President, COO and Member of the Board of DirectorsJesse Hall - Chief Medical OfficerNone - Company RepresentativeConference Call ParticipantsJeff Jones - Senior AnalystJeff JonesGood morning, everyone, and welcome back to day two of Oppenheimer's Annual Healthcare Conference. I'm Jeff Jones, one of the senior analysts on the team here, and I'm delighted to welcome multiple members from the Acla ...
Passage Bio (NasdaqGS:PASG) FY Conference Transcript
2026-02-26 14:42
Passage Bio (NasdaqGS:PASG) FY Conference February 26, 2026 08:40 AM ET Company ParticipantsWilliam Chou - President and CEOConference Call ParticipantsJay Olson - Managing Director and Senior AnalystJay OlsonHello, everyone, and welcome to Oppenheimer's 36th Annual Life Science Conference. I'm Jay Olson, one of the biotech analysts here at Oppenheimer, and it's a pleasure to welcome you to our discussion with Passage Bio, and it's an honor to introduce William Chou, the President and CEO of Passage. Thank ...
LSI Industries (NasdaqGS:LYTS) M&A announcement Transcript
2026-02-26 14:32
LSI Industries (NasdaqGS:LYTS) M&A announcement February 26, 2026 08:30 AM ET Company ParticipantsJames Clark - President and Chief Executive OfficerJames Galeese - Executive Vice President and Chief Financial OfficerJames GaleeseGood morning, ladies and gentlemen, welcome to the LSI Industries acquisition of the Royston Group conference call. All participants will be in listen-only mode. If anyone should require operator assistance during the conference, please key star and then zero on your telephone keyp ...
Restaurant Brands International (NYSE:QSR) Update / briefing Transcript
2026-02-26 14:32
Restaurant Brands International (NYSE:QSR) Update / briefing February 26, 2026 08:30 AM ET Company ParticipantsAlexandre Simon - CEOAxel Schwan - President of InternationalBorja Hernandez de Alba - CEOGregorio Jimenez - PresidentJohnson Huang - Operating Partner and ChairmanJosh Kobza - CEOKaterina Glyptis - President of Tim Hortons U.S.Kendall Peck - VP of Investor Relations and TreasuryMark Mao - CEOMike Hancock - President of Firehouse Subs U.S. and CanadaOlivier Bertrand - Founder and OwnerPatrick Doyle ...
The Carlyle Group (NasdaqGS:CG) Update / briefing Transcript
2026-02-26 14:32
The Carlyle Group (NasdaqGS:CG) Update / briefing February 26, 2026 08:30 AM ET Company ParticipantsAkhil Bansal - Head of Asset-Backed FinanceBrian Bernasek - Managing Director and Partner in Co-Head of Americas Corporate Private EquityDaniel Harris - Partner and Head of Investor RelationsHarvey Schwartz - CEOJeff Nedelman - Co-President and Global Head of Client BusinessJohn Redett - Co-President and Head of Global Private EquityJustin Plouffe - CFOLindsay LoBue - COOLúcia Soares - CIO and Head of Technol ...
International Paper (NYSE:IP) 2026 Conference Transcript
2026-02-26 14:17
International Paper (NYSE:IP) 2026 Conference February 26, 2026 08:15 AM ET Company ParticipantsAndy Silvernail - CEOModeratorOur next guest is presenting today. We have Andy Silvernail, Chief Executive Officer of International Paper. It's been kind of an interesting time last couple of weeks. What do you say, Andy?Andy SilvernailYeah.ModeratorYeah, also in the audience is Lance Loeffler, Chief Financial Officer of the company. He's been with the company since 2025, and also from the investor relations effo ...